March 20, 2018 / 11:36 AM / 6 months ago

BRIEF-Late-Breaking Clinical Trial Data Further Demonstrate Safety And Effectiveness Of Rhythmia Mapping System

March 20 (Reuters) - Boston Scientific Corp:

* LATE-BREAKING CLINICAL TRIAL DATA FURTHER DEMONSTRATE SAFETY AND EFFECTIVENESS OF THE RHYTHMIA™ MAPPING SYSTEM

* BOSTON SCIENTIFIC - DEPENDING ON ARRHYTHMIA TYPE, STUDY DATA SHOWED ACUTE SUCCESS RATE OF UP TO 95.7%

* BOSTON SCIENTIFIC - WHEN COMPLETED, VALIDATION MAPPING IDENTIFIED NEED FOR ADDITIONAL ABLATIONS IN 73% OF PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below